EndorTech
Synthetic Beta‑Endorphin Aerosol Platform for Pain Relief
Company Overview
Snapshot
Founded in June 2023 by Ronen Sasson, EndorTech operates with 1–10 employees. The company is currently in a Pre-Funding stage and holds a patent for its core technology.
Business overview
EndorTech is a Health Tech & Life Sciences company focused on developing a natural alternative to opioid pain relievers. The company's core technology involves a patented disruptive mechanism using pure synthetic aerosoled beta-endorphin, a smart protein brain food. This innovative aerosol delivery system allows for the inhalation of endorphins, aiming to provide rapid and effective pain relief without the need for pills or injections. EndorTech serves the healthcare industry, specifically targeting patients in the Drugs Discovery & Development sector.
Log in to access full profile ›Company Intelligence Q&A
- What is EndorTech's primary focus?
- EndorTech focuses on delivering commercial quantities of synthetic biological beta-endorphin as a natural alternative to current opioid pain killers, aiming for pain relief without side effects.
- When was EndorTech founded?
- EndorTech was founded in June 2023.
- Who is the founder of EndorTech?
- Ronen Sasson is the Co-founder & CEO of EndorTech.
- What is the core technology developed by EndorTech?
- EndorTech has developed a patented disruptive mechanism that uses pure synthetic aerosoled beta-endorphin for pain relief.
- What products does EndorTech offer?
- EndorTech offers products named EndoRelief, EndoRecover, and EndoElevate, which are part of its synthetic beta-endorphin aerosol platform.